Skip to main content
OpenTrials

Clinical trial condition

Primary Immunodeficiency Diseases

Explore clinical trials studying Primary Immunodeficiency Diseases. Study availability and eligibility vary by location and protocol.

161 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

Primary Immunodeficiency Diseases trial results

Completed

A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency

NCT01289847

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood Coagulation Disorders, +24 more
Locations
  • Department of Medicine, University of California Irvine, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • IMMUNOe International Reseach Centers Centennial, Colorado, United States
  • Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
View Trial Details
Completed

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

NCT01199705

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Gifu, Gifu Pref., Japan
  • Study site Sapporo, Hokkaido, Japan
View Trial Details
Completed

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

NCT01461018

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Fukuoka, Japan
  • Study site Gifu, Gifu Pref., Japan
View Trial Details
Completed

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

NCT00719680

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Contact CSL Behring for facility details Centennial, Colorado, United States
  • Contact CSL Behring for facility details North Palm Beach, Florida, United States
  • Contact CSL Behring for facility details Indianapolis, Indiana, United States
  • Contact CSL Behring for facility details Dallas, Texas, United States
View Trial Details
Completed

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)

NCT00751621

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study Site Paris, France
  • Study Site Berlin, Germany
  • Study Site Freiburg im Breisgau, Germany
  • Study Site Leipzig, Germany
View all 13 locations
View Trial Details
Completed

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

NCT01406470

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
View Trial Details
Completed

Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency

NCT00520494

Conditions
Agammaglobulinemia, Blood Protein Disorders, Bruton type agammaglobulinemia, +10 more
Locations
  • Contact CSL Behring for facility details Edmonton, Alberta, Canada
  • Contact CSL Behring for facility details Montreal, Quebec, Canada
  • Contact CSL Behring for facility details Leipzig, Germany
  • Contact CSL Behring for facility details Brescia, Italy
View Trial Details
Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

NCT00680446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Women's & Children's Hospital North Adelaide, South Australia, Australia
View Trial Details
Completed

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

NCT01458171

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Fukuoka, Japan
  • Study site Gifu, Gifu Pref., Japan
View Trial Details
Completed

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

NCT00419341

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study Site Los Angeles, California, United States
  • Study Site Los Angeles, California, United States
  • Study Site Centennial, Colorado, United States
  • Study Site North Palm Beach, Florida, United States
View all 13 locations
View Trial Details

Related conditions